Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Adial Pharmaceuticals stock
Learn how to easily invest in Adial Pharmaceuticals stock.
Adial Pharmaceuticals is a biotechnology business based in the US. Adial Pharmaceuticals shares (ADIL) are listed on the NASDAQ and all prices are listed in US Dollars. Adial Pharmaceuticals employs 16 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Adial Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ADIL. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Adial Pharmaceuticals stock price (NASDAQ: ADIL)Use our graph to track the performance of ADIL stocks over time.
Adial Pharmaceuticals shares at a glance
|Latest market close||$0.35|
|52-week range||$0.20 - $2.27|
|50-day moving average||$0.40|
|200-day moving average||$0.54|
|Wall St. target price||$7.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.67|
Buy Adial Pharmaceuticals stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Adial Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Adial Pharmaceuticals price performance over time
Historical closes compared with the close of $0.35 from 2023-03-24
|1 week (2023-03-21)||-15.66%|
|1 month (2023-02-28)||-20.45%|
|3 months (2022-12-28)||59.09%|
|6 months (2022-09-28)||-7.92%|
|1 year (2022-03-24)||-83.17%|
|2 years (2021-03-26)||-85.36%|
|3 years (2020-03-27)||1.38|
|5 years (2018-03-24)||N/A|
Adial Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-99.41%|
|Return on equity TTM||-248.96%|
|Market capitalisation||$11.8 million|
TTM: trailing 12 months
Adial Pharmaceuticals share dividends
We're not expecting Adial Pharmaceuticals to pay a dividend over the next 12 months.
Adial Pharmaceuticals share price volatility
Over the last 12 months, Adial Pharmaceuticals's shares have ranged in value from as little as $0.2 up to $2.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adial Pharmaceuticals's is 0.9831. This would suggest that Adial Pharmaceuticals's shares are less volatile than average (for this exchange).
Adial Pharmaceuticals overview
Adial Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia. .
Adial Pharmaceuticals in the news
Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder
Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14th
Meta’s stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market
Frequently asked questionsWhat percentage of Adial Pharmaceuticals is owned by insiders or institutions?
Currently 46.592% of Adial Pharmaceuticals shares are held by insiders and 19.256% by institutions. How many people work for Adial Pharmaceuticals?
Latest data suggests 16 work at Adial Pharmaceuticals. When does the fiscal year end for Adial Pharmaceuticals?
Adial Pharmaceuticals's fiscal year ends in December. Where is Adial Pharmaceuticals based?
Adial Pharmaceuticals's address is: 1180 Seminole Trail, Charlottesville, VA, United States, 22901 What is Adial Pharmaceuticals's ISIN number?
Adial Pharmaceuticals's international securities identification number is: US00688A1060 What is Adial Pharmaceuticals's CUSIP number?
Adial Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00688A106
More guides on Finder
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert